Literature DB >> 34169442

Isolated cancer stem cells from human liver cancer: morphological and functional characteristics in primary culture.

M Hu1,2, M Li3, H Huang3, C Lu3.   

Abstract

BACKGROUND: Primary liver cancer cells (PLCs) could more directly simulate the human tumor microenvironment. Compared with liver cancer cell lines, PLCs could reflect the human situation. As in previous studies, tumor stem cells were a small number of cancer cells in the microenvironment and considered to be one of the origins of liver cancer. This study aimed to screen stem cells in PLCs, analyze their biological characteristics, propose the possibility that liver cancer originated from stem cells.
METHODS: Liver cancer tissues of 17 patients were taken from the Affiliated Hospital of Guangdong Medical College, and PLCs were isolated by tissue slice method. The proliferation, tumor formation in nude mice, stem protein expression of PLCs were observed. C-kit+ liver cancer cells were screened and their biological characteristics were analyzed.
RESULTS: PLCs could be stably passaged. Transmission electron microscopy indicated that the nucleus was irregular, there were many mitochondria, and the endoplasmic reticulum was irregularly distributed. PLCs could express E-Cadherin, Oct-4, β-Catenin, Sox2, CD326, C-kit, GPC3, Nanog. The proliferation curve of PLCs and Hep3B cells were similar, and they all could form tumors in nude mice. Flow-sorted C-kit+ PLCs, as well as C-kit+ Hep3B cells could highly express Bmi1, Sox2, Oct4, Notch1, Nanog, C-kit, β-Catenin, Smo, Nestin, ABCG2, ABCB1. And they also could clone and form tumors in vivo. But C-kit+ PLCs were more sensitive to chemotherapy drugs than C-kit+ liver cancer cell lines.
CONCLUSION: C-kit+ PLCs had the characteristics of tumor stem cells and were more sensitive to chemotherapy drugs.
© 2021. Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  C-kit; Liver cancer stem cell; Primary liver cancer cell

Mesh:

Year:  2021        PMID: 34169442     DOI: 10.1007/s12094-021-02667-w

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  39 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; María Reig; Jordi Bruix
Journal:  Lancet       Date:  2018-01-05       Impact factor: 79.321

Review 2.  The stem cell division theory of cancer.

Authors:  Miguel López-Lázaro
Journal:  Crit Rev Oncol Hematol       Date:  2018-01-31       Impact factor: 6.312

Review 3.  Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies.

Authors:  C Raggi; H S Mousa; M Correnti; A Sica; P Invernizzi
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

Review 4.  Cancer stem cells and chemoresistance: The smartest survives the raid.

Authors:  Jihe Zhao
Journal:  Pharmacol Ther       Date:  2016-02-17       Impact factor: 12.310

5.  Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.

Authors:  Li Zhou; Jing-An Rui; Wei-Xun Zhou; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  Pathol Res Pract       Date:  2017-03-08       Impact factor: 3.250

6.  Visualization and targeting of LGR5+ human colon cancer stem cells.

Authors:  Mariko Shimokawa; Yuki Ohta; Shingo Nishikori; Mami Matano; Ai Takano; Masayuki Fujii; Shoichi Date; Shinya Sugimoto; Takanori Kanai; Toshiro Sato
Journal:  Nature       Date:  2017-03-29       Impact factor: 49.962

7.  Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo.

Authors:  A Blair; D E Hogge; L E Ailles; P M Lansdorp; H J Sutherland
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

Review 8.  Treatment of intermediate-stage hepatocellular carcinoma.

Authors:  Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal:  Nat Rev Clin Oncol       Date:  2014-08-05       Impact factor: 66.675

9.  Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.

Authors:  Devon A Lawson; Nirav R Bhakta; Kai Kessenbrock; Karin D Prummel; Ying Yu; Ken Takai; Alicia Zhou; Henok Eyob; Sanjeev Balakrishnan; Chih-Yang Wang; Paul Yaswen; Andrei Goga; Zena Werb
Journal:  Nature       Date:  2015-09-23       Impact factor: 49.962

Review 10.  Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications.

Authors:  Francesca Nazio; Matteo Bordi; Valentina Cianfanelli; Franco Locatelli; Francesco Cecconi
Journal:  Cell Death Differ       Date:  2019-02-06       Impact factor: 15.828

View more
  1 in total

1.  Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer.

Authors:  Linfeng Xian; Pei Zhao; Xi Chen; Zhimin Wei; Hongxiang Ji; Jun Zhao; Wenbin Liu; Zishuai Li; Donghong Liu; Xue Han; Youwen Qian; Hui Dong; Xiong Zhou; Junyan Fan; Xiaoqiong Zhu; Jianhua Yin; Xiaojie Tan; Dongming Jiang; Hongping Yu; Guangwen Cao
Journal:  Cell Oncol (Dordr)       Date:  2022-08-29       Impact factor: 7.051

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.